Bellevue Group »

Summit Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of Summit Therapeutics shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $219k 10k 21.90

More positions owned by Bellevue Group

Argenx Se Sponsored Adr (ARGX)
Ionis Pharmaceuticals (IONS)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Alnylam Pharmaceuticals (ALNY)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Boston Scientific Corporation (BSX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Intra Cellular Therapies (ITCI)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
UnitedHealth (UNH)
Moderna (MRNA)

View all positions for Bellevue Group

Top funds holding Summit Therapeutics

Group One Trading
Simplex Trading
Bellevue Group

View all funds holding Summit Therapeutics